Literature DB >> 27408342

CD5 Positive B Lymphoblastic Leukemia: Report of a Case with Review of Literature.

Sreejesh Sreedharanunni1, Narender Kumar1, Alka Khadwal2.   

Abstract

We report a rare CD5 positive B cell acute lymphoblastic leukemia (B-ALL) with a review of the clinopathological features and prognosis of previously reported cases in the literature. The aberrant expression of CD 5 antigen is uncommon in B-ALL; the morphological differential diagnosis includes blastic mantle cell lymphoma, denovo CD5(+) diffuse large B cell lymphoma and secondary diffuse large cell lymphoma/Richter's transformation. CD5(+) B cell ALL is commonly reported in younger patients (<18 years). Though the expression of T cell antigens is reported to have poor prognosis, the experience with CD5(+) B-ALL is limited to draw any firm conclusion regarding its prognosis.

Entities:  

Keywords:  Aberrant T cell antigen; B acute lymphoblastic leukemia; Leukemia associated abnormal immunophenotype (LAIP)

Year:  2014        PMID: 27408342      PMCID: PMC4925475          DOI: 10.1007/s12288-014-0485-y

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  12 in total

Review 1.  The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Authors:  Nicole Baumgarth
Journal:  Nat Rev Immunol       Date:  2010-12-10       Impact factor: 53.106

2.  Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia.

Authors:  Deborah A Thomas; Susan O'Brien; Jeffrey L Jorgensen; Jorge Cortes; Stefan Faderl; Guillermo Garcia-Manero; Srdan Verstovsek; Charles Koller; Sherry Pierce; Yang Huh; William Wierda; Michael J Keating; Hagop M Kantarjian
Journal:  Blood       Date:  2008-08-14       Impact factor: 22.113

3.  Characterization of immunophenotypic aberrancies in 200 cases of B acute lymphoblastic leukemia.

Authors:  Adam C Seegmiller; Steven H Kroft; Nitin J Karandikar; Robert W McKenna
Journal:  Am J Clin Pathol       Date:  2009-12       Impact factor: 2.493

4.  Aberrant T-cell antigen expression in B lymphoblastic leukaemia.

Authors:  Shafinaz Hussein; Kamraan Z Gill; Anthony N Sireci; Adriana I Colovai; Tania Small; Foxwell N Emmons; Vundavalli V Murty; Govind Bhagat; Bachir Alobeid
Journal:  Br J Haematol       Date:  2011-09-19       Impact factor: 6.998

5.  CD5-positive B-cell acute lymphoblastic leukemia.

Authors:  Michael R Peterson; Kyle J Noskoviak; Robert Newbury
Journal:  Pediatr Dev Pathol       Date:  2007 Jan-Feb

6.  Aberrant Immunophenotypic Expression of CD5 in a Case of B Acute Lymphoblastic Leukemia: A Case Report.

Authors:  Deepti Mutreja; Hara Prasad Pati; Divya Bansal; Rahul Kumar Sharma; Sonal Jain
Journal:  Indian J Hematol Blood Transfus       Date:  2014-02-18       Impact factor: 0.900

7.  Nonpositive terminal deoxynucleotidyl transferase in pediatric precursor B-lymphoblastic leukemia.

Authors:  Lanting Liu; Loris McGavran; Mark A Lovell; Qi Wei; Bette A Jamieson; Sara A Williams; Norma N Dirks; M Susan Danielson; Lara M Dubie; Xiayuan Liang
Journal:  Am J Clin Pathol       Date:  2004-06       Impact factor: 2.493

8.  CD5-positive acute lymphoblastic leukemia.

Authors:  Dawood Ahmed; Tahir Aziz Ahmed; Suhaib Ahmed; Hamid Nawaz Tipu; Muhammad Amin Wiqar
Journal:  J Coll Physicians Surg Pak       Date:  2008-05       Impact factor: 0.711

Review 9.  Flow cytometric immunophenotyping for hematologic neoplasms.

Authors:  Fiona E Craig; Kenneth A Foon
Journal:  Blood       Date:  2008-01-15       Impact factor: 22.113

10.  Prognostic significance of monitoring leukemia-associated immunophenotypes by eight-color flow cytometry in adult B-acute lymphoblastic leukemia.

Authors:  X-Q Weng; Y Shen; Y Sheng; B Chen; J-H Wang; J-M Li; J-Q Mi; Q-S Chen; Y-M Zhu; C-L Jiang; H Yan; X-X Zhang; T Huang; Z Zhu; Z Chen; S-J Chen
Journal:  Blood Cancer J       Date:  2013-08-16       Impact factor: 11.037

View more
  1 in total

1.  Precursor B-lineage acute lymphoblastic leukemia patients with aberrant natural killer cell and T cell - lineage antigen expression: experience from a tertiary cancer care center.

Authors:  Karthik Bommannan; Jhansi Rani Arumugam; Venkatraman Radhakrishnan; Jayachandran Perumal Kalaiyarasi; Nikita Mehra; Tenali Gnana Sagar; Shirley Sundersingh
Journal:  Hematol Transfus Cell Ther       Date:  2020-10-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.